DarioHealth Corp. (NASDAQ: DRIO)
New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:
- AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
- Personalized user experience at scale to make behavior change the path of least resistance.
Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.
Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.
Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.
Company Strategy
Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).
Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.
Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.
Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.
The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.
The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.
Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.
Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.
Financial Highlights
The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.
Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.
Value to Consumers and Businesses
Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.
Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.
Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.
Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.
Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.
Recent Studies
The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.
Remote Patient Monitoring (RPM) Agreements
The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.
This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.
Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters
In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.
As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.
Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.
Awards and Recognition
DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”
‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.
Investment Considerations
- Dario’s popular (4.9 stars on the Apple App Store and 11,000 reviews) chronic condition management platform addresses a $72 billion annual U.S. market opportunity.
- There are roughly 51,000 active users of the Dario platform, including its proprietary medical device, mobile application, and digital and human coaching services.
- Clinical studies show Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).
- Patient engagement in therapies leads to health success. The Dario platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario smartphone-connected medical devices.
- Dario is now deploying its successful B2C platform in B2B channels, targeting employers and health plans with competitive advantages spanning cost, software and hardware.
- Catasys Inc.’s (NASDAQ: CATS) C-level team (president, CMO, and head of sales) recently joined Dario to accelerate B2B penetration and revenue growth.
TraderPower Featured Companies
- 180 Life Sciences Corp. (NASDAQ: ATNF)
- AzurRx BioPharma Inc. (NASDAQ: AZRX)
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
- Canopy Rivers Inc. (TSX.V:RIV) (OTC: CNPOF)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Creatd Inc. (NASDAQ: CRTD)
- Cybin Inc. (NEO: CYBN)
- DarioHealth Corp. (NASDAQ: DRIO)
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)
- Genprex Inc. (NASDAQ: (GNPX)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK)
- Knightscope, Inc.
- Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF)
- Net Element, Inc. (NASDAQ: NETE)
- Predictive Oncology (NASDAQ: POAI)
- Pressure BioSciences Inc. (PBIO)
- Sigma Labs Inc. (NASDAQ: SGLB)
- SRAX Inc. (NASDAQ: SRAX)
- Sustainable Green Team Ltd. (SGTM)
- The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER)
- Trxade Group Inc. (NASDAQ: MEDS)
- Wrap Technologies Inc. (NASDAQ: WRTC)
Top Small Cap Market News
- $NETE Brings Former Tesla Lead on Board as VP of EV Manufacturing
- $POAI Announces Closing of $2.2 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
- $SRAX to Host, Present at B.Riley Securities 2021 Vision Day via its Virtual Events Platform
- $RACMF Announces It Will Provide Venue Management Platform for Paiute Las Vegas Golf Championship
- $AZRX Top Penny Stocks To Buy Right Now? 4 To Watch Before Next Week
- $CRTD Announces Vocal Challenges Designed to Enhance User Participation in Creator Communities
- $POAI Closes Registered Direct Offering for $2.2 Million, Announces $4.1 Million Registered Direct Offering
Recent Posts
- $POAI Closes Registered Direct Offering for $2.2 Million, Announces $4.1 Million Registered Direct Offering
- $CRTD Announces Vocal Challenges Designed to Enhance User Participation in Creator Communities
- $AZRX Top Penny Stocks To Buy Right Now? 4 To Watch Before Next Week
- $RACMF Announces It Will Provide Venue Management Platform for Paiute Las Vegas Golf Championship
- $SRAX to Host, Present at B.Riley Securities 2021 Vision Day via its Virtual Events Platform
- $POAI Announces Closing of $2.2 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
- $NETE Brings Former Tesla Lead on Board as VP of EV Manufacturing
- $GNPX Slated to Present Trailblazing Gene Therapies at the MoneyShow Accredited Investors Virtual Expo
Recent Comments
Archives
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009